Investmark Advisory Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-545
Closed -$286K 130
2025
Q1
$286K Buy
545
+1
+0.2% +$511 0.14% 97
2024
Q4
$275K Sell
544
-187
-26% -$106K 0.14% 99
2024
Q3
$427K Buy
731
+14
+2% +$7.92K 0.21% 79
2024
Q2
$365K Sell
717
-63
-8% -$30.9K 0.19% 80
2024
Q1
$386K Buy
780
+1
+0.1% +$508 0.21% 79
2023
Q4
$410K Buy
779
+1
+0.1% +$533 0.24% 76
2023
Q3
$392K Buy
778
+2
+0.3% +$984 0.27% 70
2023
Q2
$373K Buy
776
+20
+3% +$9.78K 0.25% 72
2023
Q1
$357K Sell
756
-20
-3% -$9.65K 0.26% 67
2022
Q4
$411K Buy
776
+46
+6% +$24.4K 0.3% 64
2022
Q3
$368K Buy
730
+189
+35% +$99.4K 0.33% 55
2022
Q2
$277K Sell
541
-36
-6% -$18.1K 0.27% 60
2022
Q1
$294K Sell
577
-31
-5% -$15K 0.3% 62
2021
Q4
$305K Buy
+608
New +$275K 0.29% 61

Other funds holding UNH

Investmark Advisory Group's UNH Position: Q2 2025 in Review

Investmark Advisory Group sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 545 shares — an estimated $286K sold.

Investmark Advisory Group first reported a position in UNH in Q4 2021 and held it in 14 quarters. The position peaked at $427K in Q3 2024. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Investmark Advisory Group reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Investmark Advisory Group sold 545 UnitedHealth shares in Q2 2025, an estimated $286K.
  • Investmark Advisory Group first reported a position in UnitedHealth in Q4 2021 and held it in 14 quarters.
  • Investmark Advisory Group's UnitedHealth position peaked at $427K in Q3 2024.
  • 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Investmark Advisory Group's 13F filing for Q2 2025, filed 14 Aug 2025.